BRPI0914260A2 - método de preparação de compostos bicíclicos à saber de imidazol - Google Patents
método de preparação de compostos bicíclicos à saber de imidazolInfo
- Publication number
- BRPI0914260A2 BRPI0914260A2 BRPI0914260A BRPI0914260A BRPI0914260A2 BR PI0914260 A2 BRPI0914260 A2 BR PI0914260A2 BR PI0914260 A BRPI0914260 A BR PI0914260A BR PI0914260 A BRPI0914260 A BR PI0914260A BR PI0914260 A2 BRPI0914260 A2 BR PI0914260A2
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- bicyclic compounds
- compounds namely
- imidazole
- namely imidazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7339908P | 2008-06-18 | 2008-06-18 | |
| PCT/US2009/047495 WO2010008734A2 (en) | 2008-06-18 | 2009-06-16 | Methods of Preparing Imidazole-Based Bicyclic Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0914260A2 true BRPI0914260A2 (pt) | 2015-11-03 |
Family
ID=41402541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0914260A BRPI0914260A2 (pt) | 2008-06-18 | 2009-06-16 | método de preparação de compostos bicíclicos à saber de imidazol |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7968726B2 (pt) |
| EP (1) | EP2318380B1 (pt) |
| JP (1) | JP2011524916A (pt) |
| KR (1) | KR20110019433A (pt) |
| CN (1) | CN102066344A (pt) |
| AR (1) | AR072152A1 (pt) |
| AU (1) | AU2009271409B2 (pt) |
| BR (1) | BRPI0914260A2 (pt) |
| CA (1) | CA2728097C (pt) |
| CL (1) | CL2009001437A1 (pt) |
| CO (1) | CO6341619A2 (pt) |
| ES (1) | ES2604313T3 (pt) |
| IL (1) | IL209817A0 (pt) |
| MX (1) | MX2010013817A (pt) |
| PE (1) | PE20100086A1 (pt) |
| RU (1) | RU2011101593A (pt) |
| TW (1) | TW201002698A (pt) |
| UY (1) | UY31899A (pt) |
| WO (1) | WO2010008734A2 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2401555T3 (es) * | 2008-06-18 | 2013-04-22 | Lexicon Pharmaceuticals, Inc. | Formas sólidas de (1R,2S,3R)-1-(2-(isoxazol-3-il)-1H-imidazol-4-il)butano-1,2,3,4-tetraol y métodos de utilización de las mismas |
| WO2013049272A2 (en) | 2011-09-29 | 2013-04-04 | Theraceutix, Llc | Composition and method for treatment of symptoms associated with various skin conditions |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4567194A (en) * | 1983-03-10 | 1986-01-28 | The Coca-Cola Company | 2-Acylimidazole compounds, their synthesis and use as medicinal agents |
| US4587194A (en) * | 1984-11-20 | 1986-05-06 | The Mead Corporation | Photosensitive material employing microcapsules having different photographic speeds |
| ZA974811B (en) | 1996-05-31 | 1997-12-30 | Univ Wollongong | Novel therapeutic compounds. |
| WO2007002458A2 (en) * | 2005-06-28 | 2007-01-04 | Merck & Co., Inc. | Non-nucleoside reverse transcriptase inhibitors |
| US7649098B2 (en) | 2006-02-24 | 2010-01-19 | Lexicon Pharmaceuticals, Inc. | Imidazole-based compounds, compositions comprising them and methods of their use |
| TW200848029A (en) * | 2007-03-01 | 2008-12-16 | Lexicon Pharmaceuticals Inc | Heterocyclic compounds, compositions comprising them and methods of their use |
| UY31013A1 (es) | 2007-04-12 | 2008-09-02 | Lexicon Pharmaceuticals Inc | Metodos para prepar compuestos basados en imidazol |
| ES2401555T3 (es) | 2008-06-18 | 2013-04-22 | Lexicon Pharmaceuticals, Inc. | Formas sólidas de (1R,2S,3R)-1-(2-(isoxazol-3-il)-1H-imidazol-4-il)butano-1,2,3,4-tetraol y métodos de utilización de las mismas |
-
2009
- 2009-06-10 TW TW098119434A patent/TW201002698A/zh unknown
- 2009-06-16 CN CN2009801233909A patent/CN102066344A/zh active Pending
- 2009-06-16 EP EP09744243.8A patent/EP2318380B1/en active Active
- 2009-06-16 AR ARP090102171A patent/AR072152A1/es unknown
- 2009-06-16 KR KR1020117001153A patent/KR20110019433A/ko not_active Application Discontinuation
- 2009-06-16 UY UY0001031899A patent/UY31899A/es not_active Application Discontinuation
- 2009-06-16 JP JP2011514748A patent/JP2011524916A/ja active Pending
- 2009-06-16 US US12/485,507 patent/US7968726B2/en active Active
- 2009-06-16 CA CA2728097A patent/CA2728097C/en active Active
- 2009-06-16 MX MX2010013817A patent/MX2010013817A/es not_active Application Discontinuation
- 2009-06-16 BR BRPI0914260A patent/BRPI0914260A2/pt not_active Application Discontinuation
- 2009-06-16 WO PCT/US2009/047495 patent/WO2010008734A2/en active Application Filing
- 2009-06-16 AU AU2009271409A patent/AU2009271409B2/en active Active
- 2009-06-16 PE PE2009000872A patent/PE20100086A1/es not_active Application Discontinuation
- 2009-06-16 RU RU2011101593/04A patent/RU2011101593A/ru unknown
- 2009-06-16 ES ES09744243.8T patent/ES2604313T3/es active Active
- 2009-06-17 CL CL2009001437A patent/CL2009001437A1/es unknown
-
2010
- 2010-12-07 IL IL209817A patent/IL209817A0/en unknown
-
2011
- 2011-01-18 CO CO11004599A patent/CO6341619A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2318380B1 (en) | 2016-08-24 |
| CO6341619A2 (es) | 2011-11-21 |
| MX2010013817A (es) | 2011-02-24 |
| KR20110019433A (ko) | 2011-02-25 |
| CL2009001437A1 (es) | 2010-08-20 |
| WO2010008734A3 (en) | 2010-03-11 |
| EP2318380A2 (en) | 2011-05-11 |
| IL209817A0 (en) | 2011-02-28 |
| AU2009271409A1 (en) | 2010-01-21 |
| WO2010008734A2 (en) | 2010-01-21 |
| US20090318705A1 (en) | 2009-12-24 |
| TW201002698A (en) | 2010-01-16 |
| PE20100086A1 (es) | 2010-02-08 |
| CA2728097A1 (en) | 2010-01-21 |
| AR072152A1 (es) | 2010-08-11 |
| JP2011524916A (ja) | 2011-09-08 |
| AU2009271409B2 (en) | 2014-01-30 |
| ES2604313T3 (es) | 2017-03-06 |
| CA2728097C (en) | 2017-01-03 |
| RU2011101593A (ru) | 2012-07-27 |
| US7968726B2 (en) | 2011-06-28 |
| UY31899A (es) | 2010-01-29 |
| CN102066344A (zh) | 2011-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20190526T1 (hr) | Postupak za obradu pucolana | |
| BRPI0817609A2 (pt) | Derivados de imidazol | |
| SMT201600222B (it) | Formulazione di anticorpi | |
| SMT201300045B (it) | Processi per la preparazione di composti di amminosolfone | |
| SMT201400023B (it) | Analoghi di buprenorfina | |
| BRPI0818855A2 (pt) | Derivados de imidazol | |
| IL203685A (en) | Process for the preparation of pyrolidinyl imidazole derivatives Bipnilyl Imidazole Transformed Pyrolidinyl | |
| DK2208469T3 (da) | Fremgangsmåde til fremstilling af en ortopædisk skæreblok | |
| HK1163676A1 (en) | Bicyclic heterocyclic compound | |
| DE602007009812D1 (de) | Kondensierte imidazolderivate als aromataseinhibitoren | |
| IT1396213B1 (it) | Tornio per lavorazione combinata | |
| BRPI0906098A2 (pt) | Método de preparação de um composto | |
| BRPI0815037A2 (pt) | Composto bicíclico fundido | |
| DK3214083T3 (da) | Fremgangsmåde til fremstilling af quinolonforbindelser | |
| BRPI0818786A2 (pt) | Acomodações de dois sistemas de telefonia independentes | |
| ATE446292T1 (de) | Heterocyclylamid-substituierte imidazole | |
| GB2459334B (en) | Method of positioning using satellites | |
| IT1393062B1 (it) | Procedimento per la preparazione di gemcitabina cloridrato | |
| BRPI0906441A2 (pt) | Composição de concentrado emulsificável | |
| BRPI0818863A2 (pt) | Derivados de imidazol | |
| FR2932799B1 (fr) | Procede de preparation de composes fluores | |
| ITMI20080195A1 (it) | Procedimento per la preparazione di solifenacin | |
| BRPI0914260A2 (pt) | método de preparação de compostos bicíclicos à saber de imidazol | |
| DK2254890T3 (da) | Fremgangsmåde til diastereomerisk racematspaltning af methyltetrahydrofolsyre | |
| BRPI0916970A2 (pt) | Combinações de imidazol substituído |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |